Continuous versus targeted medication in schizophrenic outpatients: outcome results
- PMID: 1974743
- DOI: 10.1176/ajp.147.9.1138
Continuous versus targeted medication in schizophrenic outpatients: outcome results
Erratum in
- Am J Psychiatry 1991 Jun;148(6):819
Abstract
The authors report on the outcome of treatment of 116 outpatients with chronic schizophrenia who were assigned to a 2-year, single-blind course of treatment with either targeted or continuous medication. These patients were not restricted to those who were good candidates for a medication reduction strategy. Continuous medication was superior to targeted medication in preventing decompensations and hospitalizations and in extent of employment at 2 years. Other measures of psychopathology and functioning at 1 and 2 years did not differentiate the two groups of patients. The targeted approach achieved a substantial reduction in total medication through a reduction in the number of days of medication administration.
Comment in
-
Targeted neuroleptic medication.Am J Psychiatry. 1991 Nov;148(11):1612-3. doi: 10.1176/ajp.148.11.aj148111612. Am J Psychiatry. 1991. PMID: 1681753 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical